June 2012 - CDC Analysis and Guidance Released

CDC Analysis and Guidance Released

The U.S. Centers for Disease Control and Prevention (CDC) assessed the evidence regarding hormonal contraceptive use and the risk for HIV acquisition, transmission, and disease progression. CDC affirmed the WHO’s recommendation, concluding that the use of hormonal contraceptives, including combined hormonal contraceptives, progestin-only pills, depot medroxyprogesterone acetate (DMPA), and implants, is safe for women at high risk for HIV infection or infected with HIV and that all women who use contraceptive methods other than condoms should be counseled regarding the use of condoms and the risk for sexually transmitted infections.

Review the Guidance